Background: Nucleic acid binding proteins are frequently targeted as autoantigens in systemic
lupus erythematosus (SLE) and other interferon (IFN)-linked rheumatic diseases. The AIM-…

Objective. Pneumocystis jiroveci pneumonia (PJP) is an opportunistic infection with high
mortality among patients with underlying rheumatologic conditions. Given the paucity of …

Background Some clinical features of severe COVID-19 represent blood vessel damage
induced by activation of host immune responses initiated by the coronavirus SARS-CoV-2. We …

SARS-CoV-2 infection induces severe disease in a subpopulation of patients, but the underlying
mechanisms remain unclear. We demonstrate robust IgM autoantibodies that recognize …

Objective Antibodies against the small ubiquitin‐like modifier (SUMO) activating enzyme (SAE)
are one of the rarer specificities associated with dermatomyositis (DM). The purpose of …

Objective We undertook this study to 1) determine the sensitivity of the European Alliance of
Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) …

Introduction The diagnosis of inclusion body myositis (IBM) can be challenging, and its
presentation can be confused with other forms of myositis or neuromuscular disorders. In this …

Mechanic’s hands is a well-characterized manifestation of select idiopathic inflammatory
myopathy (IIM) syndromes. Less well characterized is the hyperkeratosis of the toes and plantar …

The ability to accurately assay a broad range of well-defined autoantibody specificities in
myositis patients is imperative for clinical phenotyping and patient care. In myositis research, …

Objective: To describe a single-center North American adult cohort of anti-MDA5-positive
dermatomyositis patients, with emphasis on drug-free long-term remission. Methods: We …